BioSymetrics
biosymetrics.com
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
BioSymetrics applies machine learning to messy biomedical and clinical data to find new drug targets and patient subgroups. Founded in 2015 in New York, its Augusta platform automates the feature engineering step that dominates biological data science. The company works with pharmaceutical partners on rare disease and neurology programmes.
News
BioSymetrics Inc.
The Nature Index tracks the affiliations of scientific articles from high-quality publications. The research profile for BioSymetrics Inc. reflects the research output of authors from BioSymetrics Inc. who published articles in the 145 journals included i
Read more
Report
Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional ...
Read more
Report
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine
--Renovaro Biosciences Inc., a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today announced it closed its previously announced merger transaction with BioSymetrics, an artificial intelli
Read more
Report
Renovaro, BioSymetrics to merge to speed up biomarker identification, enhance drug discovery & expand precision medicine applications in cancer
Renovaro, BioSymetrics to merge to speed up biomarker identification, enhance drug discovery & expand precision medicine applications in cancer
Read more
Report
Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine
GlobeNewswire Press Release.
Read more
Report